Study of heart transplant micro-vessel disease using special tests
Part of Heart & circulation clinical trials.
This trial is for people who have had a heart transplant and are having symptoms or need routine invasive check-ups. It tests an approach aimed at better understanding and monitoring “micro-vessel” problems in the transplanted heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can legally consent and understand the study (you’ll sign consent after time to think).
- You have had a heart transplant.
- You have a reason for routine invasive heart tests, or you have symptoms that prompted them.
- In everyday life you can do moderate exercise (like cycling or climbing at least two flights of stairs) without shortness of breath or chest symptoms.
- You do not have certain conditions that affect test results or make the stress test unsafe (like pregnancy, active cancer, severe kidney failure on dialysis, or certain heart/thyroid/other urgent problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial measures how well tiny blood vessels in the heart are working in people who have had a heart transplant. It may help doctors understand transplant-related circulation problems and guide future care.
This study investigates a new heart scan (called a cardiac PET) to detect early signs of blood vessel disease in heart transplant patients. If you had your transplant 2 to 10 years ago, this scan might be an alternative to the usual yearly checkup with an invasive procedure (angiogram).
This study uses tiny particles called extracellular vesicles (which cells release) to check for signs of organ rejection after a heart transplant, aiming for a safer and less invasive alternative to biopsies.
This trial is studying whether a blood test that measures small molecules called microRNAs can help doctors personalize the medicines used to prevent rejection after a heart transplant. If you qualify, you would help researchers learn how to better match immunosuppression to each patient's needs.
This study uses advanced heart imaging and blood tests to detect a type of rejection that can happen after a heart transplant. It may help doctors diagnose antibody-mediated rejection earlier and more accurately.
This study checks if tiny blood vessel problems in the heart affect how well the heart muscle recovers after being weak. It uses special imaging during a routine heart catheterization to look at these small vessels.
Hear when a new Cardiac Allograft Vasculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.